These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25329488)

  • 1. Neoadjuvant strategies for triple negative breast cancer: 'state-of-the-art' and future perspectives.
    Carbognin L; Furlanetto J; Vicentini C; Nortilli R; Pilotto S; Brunelli M; Pellini F; Pollini GP; Bria E; Tortora G
    Anticancer Agents Med Chem; 2015; 15(1):15-25. PubMed ID: 25329488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple-negative breast cancer: advancements in characterization and treatment approach.
    Hurvitz S; Mead M
    Curr Opin Obstet Gynecol; 2016 Feb; 28(1):59-69. PubMed ID: 26694831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant therapy for triple-negative breast cancer: potential predictive biomarkers of activity and efficacy of platinum chemotherapy, PARP- and immune-checkpoint-inhibitors.
    Garufi G; Palazzo A; Paris I; Orlandi A; Cassano A; Tortora G; Scambia G; Bria E; Carbognin L
    Expert Opin Pharmacother; 2020 Apr; 21(6):687-699. PubMed ID: 32052646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection.
    Lehmann BD; Jovanović B; Chen X; Estrada MV; Johnson KN; Shyr Y; Moses HL; Sanders ME; Pietenpol JA
    PLoS One; 2016; 11(6):e0157368. PubMed ID: 27310713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant Therapy for Patients with Triple Negative Breast Cancer (TNBC).
    Liedtke C; Rody A
    Rev Recent Clin Trials; 2017; 12(2):73-80. PubMed ID: 28270088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of platinum-based neoadjuvant chemotherapy versus standard neoadjuvant chemotherapy for triple-negative breast cancer.
    Wang D; Feng J; Xu B
    Future Oncol; 2019 Aug; 15(23):2779-2790. PubMed ID: 31293180
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeted Therapies for Triple-Negative Breast Cancer.
    Lyons TG
    Curr Treat Options Oncol; 2019 Nov; 20(11):82. PubMed ID: 31754897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shifting Paradigms in TNBC Treatment: Emerging Alternatives to Capecitabine in the Post-Neoadjuvant Setting.
    Abahssain H; Souadka A; Alem R; Santoni M; Battelli N; Amela E; Lemaire A; Rodriguez J; Errihani H
    Curr Oncol; 2024 Jun; 31(7):3771-3782. PubMed ID: 39057150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The landscape of systemic therapy for early stage triple-negative breast cancer.
    Lu JY; Alvarez Soto A; Anampa JD
    Expert Opin Pharmacother; 2022 Aug; 23(11):1291-1303. PubMed ID: 35818711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
    Tanino H; Kosaka Y; Nishimiya H; Tanaka Y; Minatani N; Kikuchi M; Shida A; Waraya M; Katoh H; Enomoto T; Sengoku N; Kajita S; Hoffman RM; Watanabe M
    PLoS One; 2016; 11(12):e0165721. PubMed ID: 27935989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future Developments in Neoadjuvant Therapy for Triple-Negative Breast Cancer.
    Moore-Smith L; Forero-Torres A; Stringer-Reasor E
    Surg Clin North Am; 2018 Aug; 98(4):773-785. PubMed ID: 30005773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platinum agents in the treatment of early-stage triple-negative breast cancer: is it time to change practice?
    Agrawal LS; Mayer IA
    Clin Adv Hematol Oncol; 2014 Oct; 12(10):654-8. PubMed ID: 25658890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple-Negative Breast Cancer: Who Should Receive Neoadjuvant Chemotherapy?
    Chaudhary LN; Wilkinson KH; Kong A
    Surg Oncol Clin N Am; 2018 Jan; 27(1):141-153. PubMed ID: 29132557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Therapeutic Strategies for Triple-Negative Breast Cancer.
    Székely B; Silber AL; Pusztai L
    Oncology (Williston Park); 2017 Feb; 31(2):130-7. PubMed ID: 28205193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
    Bonsang-Kitzis H; Chaltier L; Belin L; Savignoni A; Rouzier R; Sablin MP; Lerebours F; Bidard FC; Cottu P; Sastre-Garau X; Laé M; Pierga JY; Reyal F
    PLoS One; 2015; 10(12):e0144359. PubMed ID: 26684197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects.
    Jia H; Truica CI; Wang B; Wang Y; Ren X; Harvey HA; Song J; Yang JM
    Drug Resist Updat; 2017 May; 32():1-15. PubMed ID: 29145974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of Triple Negative Breast Cancer After Neoadjuvant Chemotherapy.
    Aldrich J; Canning M; Bhave M
    Clin Breast Cancer; 2023 Dec; 23(8):832-834. PubMed ID: 37596146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ¹⁸F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen.
    Groheux D; Biard L; Giacchetti S; Teixeira L; Hindié E; Cuvier C; Vercellino L; Merlet P; de Roquancourt A; de Cremoux P; Resche-Rigon M; Espié M
    J Nucl Med; 2016 Apr; 57(4):536-43. PubMed ID: 26697967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Evolution of Triple-Negative Breast Cancer: From Biology to Novel Therapeutics.
    Anders CK; Abramson V; Tan T; Dent R
    Am Soc Clin Oncol Educ Book; 2016; 35():34-42. PubMed ID: 27249684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Best Foot Forward: Neoadjuvant Systemic Therapy as Standard of Care in Triple-Negative and HER2-Positive Breast Cancer.
    Sharma P; Connolly RM; Roussos Torres ET; Thompson A
    Am Soc Clin Oncol Educ Book; 2020 Mar; 40():1-16. PubMed ID: 32315235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.